Tag: regkirona

regkirona

Latest News

A Celltrion researcher holds a vial of CT-P59, the company's Covid-19 treatment. [NEWS1]

Celltrion's $521 million net is up 20.1%

Celltrion reported 623.7 billion won ($521 million) in net profit in 2021, up 20.1 percent on year, according to a regulatory filing on Wednesday.

2022.2.16

Inhalable Regkirona found safe in Phase 1 clinical trial

Celltrion said Monday Phase 1 clinical trials of an inhalable form of Regkirona produced meaningful results confirming safety.

2022.2.7

Most popular

Celltrion’s Regkirona, the first homegrown Covid-19 treatment [CELLTRION]

Regkirona gets temporary approval from Switzerland

Regkirona, Korea’s first Covid-19 treatment, won two-year temporary use authorization from regulators in Switzerland, developer Celltrion said Friday.

2022.1.14

Celltrion’s Regkirona, the first homegrown Covid-19 treatment [CELLTRION HEALTHCARE]

Regkirona deals signed with 18 countries by Celltrion Healthcare

Celltrion Healthcare has signed deals for Regkirona, Korea's first Covid-19 treatment, with 18 countries.

2021.12.9

Regkirona gets conditional use approval in Australia

Regkirona, Korea’s first Covid-19 treatment, won conditional use approval from regulators in Australia, manufacturer Celltrion said Tuesday.

2021.12.7

Celltrion's Regkirona Covid-19 treatment [YONHAP]

Celltrion Healthcare signs Regkirona deals with 9 European countries

Celltrion Healthcare has signed agreements with nine European countries for the distribution of Regkirona, Korea's first Covid-19 treatment.

2021.11.30

Celltrion's Regkirona receives conditional approval from Peru

Regkirona, Korea’s first Covid-19 treatment, won conditional use approval from regulators in Peru, Celltrion said Monday.

2021.11.22

Regkirona receives marketing approval from European Commission

Regkirona, Korea’s first Covid-19 treatment, won marketing approval from the European Commission, Celltrion said Monday.

2021.11.15

Celltrion's Covid-19 treatment Regkirona [CELLTRION]

Celltrion seeks marketing registration for Regkirona in Europe

Celltrion said Tuesday it applied to the European Medicines Agency (EMA) for a marketing authorization for Regkirona, its Covid-19 treatment.

2021.10.5

Ministry of drug safety approves use of Celltrion’s Covid-19 treatment

Celltrion’s Covid-19 treatment Regkirona was approved for use by the Ministry of Food and Drug Safety, the Korean bio company said Friday.

2021.9.17